EURO-NMD Genetics Month Webinar Series
As part of Genetics Month, EURO-NMD is pleased to host a four-episode webinar series bringing…
November 25, 2025
Home > All posts > Breaking news >
Breaking news
Search criteria
Read the post
Joint Transnational Call 2026 – Funding Opportunities for Diagnostic Research
The Joint Transnational Call 2026 – “Resolving unsolved cases in rare genetic and non-genetic diseases”…
New CPMS Day #3: Peripheral Neuropathies – 18 December 2025
Third CPMS Day – 18 December 2025 EURO-NMD is pleased to announce the Third CPMS…
EURO-NMD Webinar Series: Neuromuscular Junction Disorders
EURO-NMD is pleased to announce a new series of webinars focusing on Neuromuscular Junction Disorders…
CPMS Training Sessions for Clinicians and Assistants
Boost collaboration, Improve patient care, Master CPMS. Join our upcoming online training sessions and learn…
EURO-NMD Mitochondrial Month – Webinar Series | September 2025
EURO-NMD is pleased to announce the 2025 edition of its Mitochondrial Month Webinar Series, which…
Call for Volunteers – EMQN Assessors for EQA Scheme Neuromuscular Disorders (NMDs)
Exciting opportunity to join the EMQN Team as a Volunteer Assessor for the new Neuromuscular…
For an EU commitment to tackling Rare Diseases – RESULTS OF CONFERENCE (Budapest 2024)
The conference aimed to shape a European policy framework for rare diseases, integrating strategies in…
EURO-NMD Webinar Series on Dysimmune and inflammatory neuropathies! (Replay available now!)
The ERN EURO-NMD Working Group on Peripheral Nerve Diseases is pleased to present a Webinar…
“Survey on unmet needs in personalised medicine management and the potential of personalised health technologies for healthcare professionals”
We have received through the ERICA project a request from the EC do promote this…
Screen4Care launches recruitment for Newborn Screening
The Screen4Care project, an innovative European research initiative, has launched recruitment for its newborn screening…
ERN EURO-NMD Retrospective of 2024
A Year of Growth and Impact As 2024 approaches its end, we are proud to…